Edit |   |
---|---|
Antigenic Specificity | CD276, Human (Enoblituzumab biosimilar) |
Clone | Enoblituzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD276 Recombinant Antibody (Enoblituzumab). Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1 monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators. This drug was developed by MacroGenics, Inc. |
Immunogen | n/a |
Other Names | Anti-CD276 Recombinant Antibody, Research Grade Enoblituzumab, Anti-Human CD276 Recombinant Antibody(Enoblituzumab), MG-A271, Antibody Drug Analogues, Monoclonal Antibody, YR1399, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1353485-38-7 |
Catalog # | YR1399 |
Price | please inquire |
Order / More Info | CD276, Human (Enoblituzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |